Maja Puchades

Summary

Country: Sweden

Publications

  1. ncbi request reprint Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease
    Maja Puchades
    Unit of Experimental Neuroscience, Department of Clinical Neuroscience, Goteborg University, Sahlgrenska University Hospital Molndal, S 431 80 Molndal, Goteborg, Sweden
    Brain Res Mol Brain Res 118:140-6. 2003
  2. ncbi request reprint Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expression
    Maja Puchades
    Institute of Neuroscience and Physiology, Sahlgrenska Academy, Goteborg University, SU Mölndal, SE 43180 Molndal, Sweden
    J Proteome Res 6:869-75. 2007

Detail Information

Publications2

  1. ncbi request reprint Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease
    Maja Puchades
    Unit of Experimental Neuroscience, Department of Clinical Neuroscience, Goteborg University, Sahlgrenska University Hospital Molndal, S 431 80 Molndal, Goteborg, Sweden
    Brain Res Mol Brain Res 118:140-6. 2003
    ..The levels of 37 proteins spots were altered in AD patients. One of the identified proteins, alpha-2-HS glycoprotein, has not previously been linked to AD. Our study shows that several glycoproteins are altered in AD...
  2. ncbi request reprint Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expression
    Maja Puchades
    Institute of Neuroscience and Physiology, Sahlgrenska Academy, Goteborg University, SU Mölndal, SE 43180 Molndal, Sweden
    J Proteome Res 6:869-75. 2007
    ..These results demonstrate the utility of using proteomic approaches to interrogate and identify potential useful targets for cancer therapy by evaluating specific tumor responses, either positive or negative, to various therapies...